SequelSEC

PURE BIOSCIENCE, INC. PURE

Miscellaneous Chemical Products · CIK 0001006028 · Fiscal year ends 0731

AnnualQuarterlyTTM
Revenue
$2.42M
Fiscal year ended 2026-04-30
Operating income
-$1.92M
Fiscal year ended 2026-04-30
Free cash flow
Unavailable
Fiscal year ended 2026-04-30

PURE BIOSCIENCE, INC. (PURE) reported revenue of $2.42M and net income of -$2.20M for the fiscal year ended 2026-04-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PURE BIOSCIENCE, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Chemical Products.

Income

PURE BIOSCIENCE, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-30
Revenue$2.42M
Cost of revenue$997.00K
Gross profit$1.42M
Operating income-$1.92M
Net income-$2.20M
Research & development$312.00K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$3.03M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

PURE BIOSCIENCE, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-30
Cash & equivalents$983.00K
Total assets$1.56M
Current assets$1.55M
Total liabilities$7.40M
Current liabilities$3.65M
Total equity incl. NCI-$5.84M
Temporary (mezzanine) equityUnavailable
Inventory$232.00K
Accounts receivable$242.00K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$719.00K

Cash flow

PURE BIOSCIENCE, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-30
Operating cash flow-$1.78M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$2.22M
Net change in cash$443.00K
Stock-based compensation$177.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

PURE BIOSCIENCE, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-30
Free cash flowUnavailable
Gross margin58.9%
Operating margin-79.2%
FCF marginUnavailable
SBC / revenue7.3%
Current ratio0.42x
Revenue YoY growth26.9%
Net margin-91.1%
R&D / revenue12.9%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PURE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-06-15View SEC filing
10-Q · Filed 2026-03-17View SEC filing
10-Q · Filed 2025-12-15View SEC filing
10-K · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-06-16View SEC filing
10-Q · Filed 2025-03-17View SEC filing

Companies in the same industry

ARQ ASPI CBT ESI FSI FTK OEC WDFC

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.